NeuBase Therapeutics, Inc.

NasdaqCM:NBSE Stock Report

Market Cap: US$1.4m

NeuBase Therapeutics Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Ownership Breakdown

What is the ownership structure of NBSE?
Owner TypeNumber of SharesOwnership Percentage
Private Companies194,9295.2%
Individual Insiders235,7596.28%
Institutions738,63119.7%
General Public2,582,27168.8%

Dilution of Shares: Shareholders have been substantially diluted in the past year, with total shares outstanding growing by 121.9%.

Top Shareholders

Top 25 shareholders own 31.17% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
6.14%
Dietrich Stephan
230,512US$87.1k0%no data
5.13%
Symetryx Corporation
192,481US$72.8k0%no data
3.63%
Greenlight Capital, Inc.
136,350US$51.5k0%no data
2.92%
Barry Shiff Registered Retirement Savings Plan
109,508US$41.4k0%no data
2.16%
Aleta Shiff Registered Retirement Savings Plan
80,973US$30.6k0%no data
2%
Kershner Trading Group LLC, Asset Management Arm
74,861US$28.3k0%1.68%
1.75%
UBS Asset Management AG
65,724US$24.8k0%no data
1.67%
Point72 Asset Management, L.P.
62,500US$23.6k0%no data
1.52%
Renaissance Technologies LLC
56,967US$21.5k0%no data
1.25%
Carnegie Mellon University Endowment Arm
46,970US$17.8k0%0.03%
0.56%
Two Sigma Investments, LP
21,083US$8.0k0%no data
0.51%
The Vanguard Group, Inc.
18,981US$7.2k0%no data
0.44%
Kestra Advisory Services, LLC
16,476US$6.2k-8.34%no data
0.42%
Jacob Asset Management of New York LLC
15,655US$5.9k0%0.01%
0.41%
Prelude Capital Management, LLC
15,550US$5.9k0%no data
0.41%
Geode Capital Management, LLC
15,482US$5.9k0%no data
0.065%
Tower Research Capital LLC
2,448US$925.30.66%no data
0.06%
Eric Richman
2,247US$849.30%no data
0.04%
Todd Branning
1,500US$567.00%no data
0.04%
Dov Goldstein
1,500US$567.00%no data
0.021%
Merrill Lynch & Co. Inc., Banking Investments
791US$298.90%no data
0.0094%
First Manhattan Co. LLC
353US$133.4-50%no data
0.008%
Royal Bank of Canada, Banking & Securities Investments
300US$113.4-17.1%no data
0.0013%
Wells Fargo & Company, Securities and Brokerage Investments
50US$18.90%no data
0.00077%
Wells Fargo & Company, Private Banking and Investment Banking Arm
29US$10.90%no data

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/05/13 02:59
End of Day Share Price 2024/05/13 00:00
Earnings2023/03/31
Annual Earnings2022/09/30

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

NeuBase Therapeutics, Inc. is covered by 6 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Thomas ShraderBTIG
Whitney IjemGuggenheim Securities, LLC
Raghuram SelvarajuH.C. Wainwright & Co.